Central or Peripheral Catheters for Initial Venous Access of ICU Patients: A Randomized Controlled Trial

被引:78
|
作者
Ricard, Jean-Damien [1 ,2 ]
Salomon, Laurence [3 ]
Boyer, Alexandre [4 ]
Thiery, Guillaume [5 ]
Meybeck, Agnes [1 ]
Roy, Carine [6 ,7 ]
Pasquet, Blandine [6 ,7 ]
Le Miere, Eric [1 ]
Dreyfuss, Didier [1 ,2 ]
机构
[1] Hop Louis Mourier, AP HP, Serv Reanimat Medicochirurg, F-92701 Colombes, France
[2] Univ Paris Diderot, Sorbonne Paris Cite, UMRS 722, F-75018 Paris, France
[3] Hop Louis Mourier, AP HP, Dept Sante Publ, F-92701 Colombes, France
[4] Hop Pellegrin Tripode, Serv Reanimat Med, Bordeaux, France
[5] Hop St Louis, AP HP, Serv Reanimat Med, Paris, France
[6] Hop Bichat Claude Bernard, AP HP, Dept Biostat, F-75877 Paris, France
[7] Hop Bichat Claude Bernard, AP HP, Rech Clin, F-75877 Paris, France
关键词
catheters; complications; nosocomial infection; quality of care; venous access; CRITICALLY-ILL PATIENTS; PREVENTION; INFECTION; COMPLICATIONS; PREVALENCE; PNEUMONIA; MEDICINE; DEVICES; RISK;
D O I
10.1097/CCM.0b013e31828a42c5
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objectives: The vast majority of ICU patients require some form of venous access. There are no evidenced-based guidelines concerning the use of either central or peripheral venous catheters, despite very different complications. It remains unknown which to insert in ICU patients. We investigated the rate of catheter-related insertion or maintenance complications in two strategies: one favoring the central venous catheters and the other peripheral venous catheters. Design: Multicenter, controlled, parallel-group, open-label randomized trial. Setting: Three French ICUs. Patients: Adult ICU patients with equal central or peripheral venous access requirement. Intervention: Patients were randomized to receive central venous catheters or peripheral venous catheters as initial venous access. Measurements and Results: The primary endpoint was the rate of major catheter-related complications within 28 days. Secondary endpoints were the rate of minor catheter-related complications and a composite score-assessing staff utilization and time spent to manage catheter insertions. Analysis was intention to treat. We randomly assigned 135 patients to receive a central venous catheter and 128 patients to receive a peripheral venous catheter. Major catheter-related complications were greater in the peripheral venous catheter than in the central venous catheter group (133 vs 87, respectively, p = 0.02) although none of those was life threatening. Minor catheter-related complications were 201 with central venous catheters and 248 with peripheral venous catheters (p = 0.06). 46% (60/128) patients were managed throughout their ICU stay with peripheral venous catheters only. There were significantly more peripheral venous catheter-related complications per patient in patients managed solely with peripheral venous catheter than in patients that received peripheral venous catheter and at least one central venous catheter: 1.92 (121/63) versus 1.13 (226/200), p < 0.005. There was no difference in central venous catheter-related complications per patient between patients initially randomized to peripheral venous catheters but subsequently crossed-over to central venous catheter and patients randomized to the central venous catheter group. Kaplan-Meier estimates of survival probability did not differ between the two groups. Conclusion: In ICU patients with equal central or peripheral venous access requirement, central venous catheters should preferably be inserted: a strategy associated with less major complications.
引用
收藏
页码:2108 / 2115
页数:8
相关论文
共 50 条
  • [31] Impact of an interventional bundle on complications associated with peripheral venous catheters in elderly patients
    Perez-Granda, Maria Jesus
    Irigoyen-von-Sierakowski, Alvaro
    Toledo, Neera
    Rodriguez, Eva
    Cruz, Maria Luisa
    Hernanz, Giovanna
    Serra, Jose Antonio
    Kestler, Martha
    Munoz, Patricia
    Guembe, Maria
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2024, 43 (04) : 703 - 712
  • [32] Ultrasound-guidance of peripheral venous catheterization in apheresis minimizes the need for central venous catheters
    Soderstrom, Anna
    Norgaard, Maria S.
    Thomsen, Anna-Marie E.
    Sorensen, Betina S.
    JOURNAL OF CLINICAL APHERESIS, 2020, 35 (03) : 200 - 205
  • [33] Bismuth coating of non-tunneled haemodialysis catheters reduces bacterial colonization: a randomized controlled trial
    Schindler, Ralf
    Heemann, Uwe
    Haug, Ulrike
    Stoelck, Benjamin
    Karatas, Aysun
    Pohle, Cosima
    Deppisch, Reinhold
    Beck, Werner
    Hollenbeck, Markus
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (08) : 2651 - 2656
  • [34] The effectiveness of chlorhexidine-silver sulfadiazine impregnated central venous catheters in patients receiving high-dose chemotherapy followed by peripheral stem cell transplantation
    Maaskant, J. M.
    De Boer, J. P.
    Dalesio, O.
    Holtkamp, M. J.
    Lucas, C.
    EUROPEAN JOURNAL OF CANCER CARE, 2009, 18 (05) : 477 - 482
  • [35] Immediate access arteriovenous grafts versus tunnelled central venous catheters: study protocol for a randomised controlled trial
    Aitken, Emma
    Geddes, Colin
    Thomson, Pete
    Kasthuri, Ram
    Chandramohan, Mohan
    Berry, Colin
    Kingsmore, David
    TRIALS, 2015, 16
  • [36] Protect peripheral intravenous catheters: a study protocol for a randomised controlled trial of a novel antimicrobial dressing for peripheral intravenous catheters (ProP trial)
    Rickard, Claire M.
    Drugeon, Bertrand
    Ullman, Amanda
    Marsh, Nicole M.
    Corley, Amanda
    Ball, Daner
    O'Brien, Catherine
    Kleidon, Tricia M.
    Guenezan, Jeremy
    Couvreur, Raphael
    McCarthy, Kate L.
    Seguin, Sabrina
    Batiot, Guillaume
    Byrnes, Joshua
    Schults, Jessica
    Zahir, Syeda Farah
    Mimoz, Olivier
    BMJ OPEN, 2024, 14 (07): : e084313
  • [37] Reduced colonization and infection with miconazole-rifampicin modified central venous catheters:: a randomized controlled clinical trial
    Yücel, N
    Lefering, R
    Maegele, M
    Max, M
    Rossaint, R
    Koch, A
    Schwarz, R
    Korenkov, M
    Beuth, J
    Bach, A
    Schierholz, J
    Pulverer, G
    Neugebauer, EAM
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (06) : 1109 - 1115
  • [38] Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial
    Young, Annie M.
    Billingham, Lucinda J.
    Begum, Gulnaz
    Kerr, David J.
    Hughes, Ana I.
    Rea, Daniel W.
    Shepherd, Stephen
    Stanley, Andrew
    Sweeney, Ann
    Wilde, Jonathan
    Wheatley, Keith
    LANCET, 2009, 373 (9663) : 567 - 574
  • [39] Effects of a Clinically Indicated Peripheral Intravenous Replacement on Indwelling Time and Complications of Peripheral Intravenous Catheters in Pediatric Patients: A Randomized Controlled Trial
    Lin, Su-Wen
    Chen, Shu-Ching
    Huang, Fang-Yi
    Lee, Ming-Ying
    Chang, Chun-Chu
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (07)
  • [40] A randomized controlled trial and cost-effectiveness analysis of early cannulation arteriovenous grafts versus tunneled central venous catheters in patients requiring urgent vascular access for hemodialysis
    Aitken, Emma
    Thomson, Peter
    Bainbridge, Leigh
    Kasthuri, Ram
    Mohr, Belinda
    Kingsmore, David
    JOURNAL OF VASCULAR SURGERY, 2017, 65 (03) : 766 - 774